These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1470301)

  • 41. Modification of the anxiolytic effects of 5-HT1A agonists by shock intensity.
    Meneses A; Hong E
    Pharmacol Biochem Behav; 1993 Nov; 46(3):569-73. PubMed ID: 7904070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G; Perrault G; Sanger DJ
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs.
    De Vry J; Benz U; Schreiber R; Traber J
    Eur J Pharmacol; 1993 Nov; 249(3):331-9. PubMed ID: 7904565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam.
    Nunes-de-Souza RL; Canto-de-Souza A; da-Costa M; Fornari RV; Graeff FG; Pelá IR
    Psychopharmacology (Berl); 2000 Jun; 150(3):300-10. PubMed ID: 10923758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hippocampal asymmetry in the behavioral responses to the 5-HT1A receptor agonist 8-OH-DPAT.
    Belcheva I; Belcheva S; Petkov VV; Petkov VD
    Brain Res; 1994 Mar; 640(1-2):223-8. PubMed ID: 7911727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of repeated treatment with 5-HT1A agonists on active avoidance responding in the rat.
    Ensler K; Ryan CN; Evenden JL
    Psychopharmacology (Berl); 1993; 112(1):45-54. PubMed ID: 7871009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm.
    Inoue T; Tsuchiya K; Koyama T
    Pharmacol Biochem Behav; 1996 Apr; 53(4):825-31. PubMed ID: 8801584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
    Meert TF
    Alcohol Alcohol; 1993 Mar; 28(2):157-70. PubMed ID: 8517886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment.
    Siemiatkowski M; Sienkiewicz-Jarosz H; Członkowska AI; Bidziński A; Płaźnik A
    Pharmacol Biochem Behav; 2000 Jul; 66(3):645-51. PubMed ID: 10899383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of 5-HT1A receptor ligands on a safety signal withdrawal procedure of conflict in the rat.
    Charrier D; Dangoumau L; Hamon M; Puech AJ; Thiébot MH
    Pharmacol Biochem Behav; 1994 May; 48(1):281-9. PubMed ID: 7913228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitory effect of buspirone and diazepam, but not of 8-OH-DPAT, on maternal behavior and aggression.
    Ferreira A; Picazo O; Uriarte N; Pereira M; Fernández-Guasti A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):389-96. PubMed ID: 10880695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K; Handley SL
    Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
    Kulikov AV; Kolpakov VG; Maslova GB; Kozintsev I; Popova NK
    Psychopharmacology (Berl); 1994 Feb; 114(1):172-4. PubMed ID: 7846200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat.
    King CM; Gommans J; Joordens RJ; Hijzen TH; Maes RA; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):121-8. PubMed ID: 9163558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.